The global advanced bipolar direct energy devices market size was valued at USD 1.14 billion in 2018 and is anticipated to expand further at a CAGR of 14.2% from 2019 to 2026. The product offers several benefits, such as it is useful in treating skin injuries and can also be used for treatment in gynecological and gastroenterology surgeries. Thus, high awareness levels among surgeons about these benefits and demand for bipolar electrosurgical devices are expected to be the key factors driving the market.
Advanced bipolar direct energy devices include an electrosurgical generator system and bipolar electrosurgical devices that are used in laparoscopic surgeries, such as gynecological procedures. Electrosurgical generator system is controlled by electrodes and offers performance and safety features, independent activation of accessories, and monitoring system, which reduces the risk of burns. Bipolar electrosurgical devices use high-frequency electrical current to desiccate, coagulate, and fulgurate tissues using bipolar energy.
In coagulation mode, waveform with lower average power generates heat for explosive vaporization for tissues. In desiccation, lower amount of heat is generated through electrodes, which are used for treatment of nodules under the skin. In fulguration mode, current is spread over the tissue areas, which is used for operating protrusive lesions. These electrosurgical modalities are useful in laparoscopic procedures.
Thus, increasing number of laparoscopic surgeries being performed is projected to help boost the product demand. Increasing demand for minimally invasive surgeries is also likely to augment the advanced bipolar direct energy devices market growth. In addition, specialized product features, such as lower voltage current that uses less energy for coagulation and cutting of large bleeding areas, are likely to drive the demand further. It gives better control for targeted areas, prevent damages to the sensitive part of tissues, and reduces the risk of burns.
Electrosurgical generator system segment is one of the fastest growing segments and also dominated the market in the forecast period owing to factors such as new product launches by the major market players and its safety features. For instance, Medtronic electrosurgical generators offers safety and effective performance features including isolated output, independent activation of accessories and patented Valleylab REM quality monitoring system which reduces the risk of burns under patient return electrode. Electrosurgical generator system offers various benefits such as it allows less operating time, reduces bleeding, cost-effective as compare to laser surgeries and requires less post-operative time for recovery. Thus, due to its several benefits this segment is expected to grow during the forecast period.
Hospitals segment is expected to lead the market owing to increasing number of gynecological and gastrological surgeries being performed in these healthcare settings. Moreover, hospitals have a separate unit for performing electrosurgeries, known as Electrosurgical Units (ESU), which include electrical equipment used in laparoscopic surgeries, such as gynecological and gastrological surgeries. In addition, availability of highly specialized and skilled surgeons boosts the segment growth further.
On the other hand, Ambulatory Surgical Centers (ASCs) is the fastest-growing end-use segment as ASCs offer outpatient services that provide quality care and help patients recover faster. For instance, Bovie IDS series uses electrosurgical generators for ASCs. IDS technology allows surgeons to perform with user-friendly interface and maximum safety; thereby, reducing patient stays and recovery time.
North America led the global market and is expected to witness substantial growth in future as well due to increasing cases of laparoscopic surgeries, awareness about advanced products, and presence of well-established healthcare facilities along with the availability of specialized surgeons. Quick adoption of technologically advanced products is expected to drive the growth further. In addition, increasing reimbursements for innovations in devices is likely to have a positive impact on the regional market.
Asia Pacific is expected to register the highest CAGR of 15.2% from 2019 to 2026 due to increasing awareness among surgeons and demand for gynecological surgeries. Growing target population, rapidly expanding medical tourism market, supportive government initiatives, and availability of skilled surgeons are several other factors driving the market growth in Asia Pacific region.
一些大公司的市场是Bovie Medical Corporation, Medtronic PLC, B. Braun Melsungen AG, XCELLANCE Medical Technologies, Karl Storz, and Olympus Corporation. These companies focus on new product development, technological advancements, and growth strategies, such as mergers and acquisitions. For instance, Olympus ESG-100 electrosurgical generator, which offers a safety energy solution and easy-to-use technology for better performance.
Report Attribute |
Details |
Market size value in 2020 |
USD 1.5 billion |
Revenue forecast in 2026 |
USD 3.3 billion |
Growth Rate |
CAGR of 14.2% from 2019 to 2026 |
Base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, end use, region |
Regional scope |
北美;欧洲;亚太地区;拉丁美洲; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Russia; China; Japan; India; Australia; South Korea; Singapore; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Bovie Medical Corporation; Medtronic; B.Braun Melsungen AG; XCELLANCE Medical Technologies; Karl Storz; Olympus Corporation |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs.Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global advanced bipolar direct energy devices market report on the basis of product, end use, and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Electrosurgical Generator Systems
Bipolar Electrosurgical Devices
End Use Outlook (Revenue, USD Million, 2015 - 2026)
Hospitals
Clinics
Ambulatory Surgical Centers (ASCs)
RegionalOutlook(Revenue, USD Million, 2015 - 2026)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Asia Pacific
China
Japan
India
Australia
South Korea
Singapore
拉丁美洲
Brazil
Mexico
Argentina
Columbia
Middle East and Africa (MEA)
South Africa
沙特阿拉伯
UAE
b.The global advanced bipolar direct energy devices market size was estimated at USD 1.3 billion in 2019 and is expected to reach USD 1.5 billion in 2020.
b.The global advanced bipolar direct energy devices market is expected to witness a compound annual growth rate of 14.2% from 2019 to 2026 to reach USD 3.3 billion by 2026.
b.North America held the largest share of 34.9% in 2019 due to the adoption of technologically advanced products, presence of well-established healthcare facilities and increasing awareness about the advanced bipolar direct energy devices in the region.
b.Some of the key players operating in the market are Bovie Medical Corporation, Medtronic, B.Braun Melsungen AG, XCELLANCE Medical Technologies, Karl Storz, and Olympus Corporation.
b.Increasing adoption of bipolar electrosurgical devices over conventional devices and technological advancements is expected to boost the adoption of telemedicine over the forecast period.
"The quality of research they have done for us has been excellent."